Oncology Research

Papers
(The TQCC of Oncology Research is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Galectins dysregulation: A way for cancer cells to invade and pervade36
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities29
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells26
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP125
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer24
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations22
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany21
lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition21
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma21
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis20
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway19
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer19
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data18
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis17
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells17
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms16
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells15
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas14
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer14
The role of LIN28B in tumor progression and metastasis in solid tumor entities14
Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network13
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?12
MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783]12
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma11
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells11
Retraction notice to High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells [Oncology Research 27(9) (2019) 102511
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials11
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells10
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer10
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance10
Erratum: Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells10
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer10
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study10
Deoxynortryptoquivaline: A unique antiprostate cancer agent10
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells10
0.035192012786865